Frequency of dosing is far more likely to result in higher expression compared to dose levels done once per week
At a small fractional profit. You sold before approval. But ya best equity analyst on the universe sold in his personal account. All twelve shares no less.
Sad little one
There was a request by one person at FDA to have the published paper retracted, not the approval. The journal of Neurology editor said no, the data stands as is. FDA is still unable to understand the fiber count data, experts like the editor in chief of the journal of Neurology do. This story is a scam pushed by those who lost.
You go with that if it makes you feel better.
This is a common delusion for biotech investors after a failure like this. So let's be clear. It failed and not for imagined conspiracy theory such as this. There was no disease incidence, bad luck, but fact is it happens all the time. We all wish it was different. It is not. It failed
A patent that is not protecting one of SRPT drugs. The patents for SRPTs actuall drugs prevailed and BMRN lost those weak attempts to claim structures they do not have. SRPT will not pay a sub license to BMRN. Period.
Posting lies again about a stock you ate short on. Knock knock. Ignore reality as you see fit but posting outright fabrications such ' no years inventory' will get you a visit from SEC.
The program has now 'sunset' provisions from this spring. This is it, there is unlikely to be another issued. It will go for more than the last.
The inventory you fail to appreciate is in the report. It was zero value until Monday. Now idiot it is quite valuable as it represents a year of sales with a COG that is a sunk cost now, part of that burn rate you cry about day after pathetic day.
Then comes the 400M cash they will bank shortly for sale of the PRV. Why don't you ever mention the PRV? Do you even know what it is? Did you see the last PRV sale? Most sell for 300-350 M but since the program is winding down this is perhaps the last PRV that will be granted, making it even more valuable. If you could only read a spread sheet